0.2158 USD
-0.01 (-3.36%)
0.2093 USD
-0.01 (-3.01%)
Taking everything into account, ZJYL scores 4 out of 10 in our fundamental rating. ZJYL was compared to 186 industry peers in the Health Care Equipment & Supplies industry. ZJYL has only an average score on both its financial health and profitability. ZJYL does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year ZJYL was profitable.
In the past year ZJYL had a positive cash flow from operations.
ZJYL had positive earnings in each of the past 5 years.
ZJYL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ZJYL's Return On Assets of 3.69% is fine compared to the rest of the industry. ZJYL outperforms 79.57% of its industry peers.
The Return On Equity of ZJYL (6.42%) is better than 80.11% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.84%, ZJYL is in the better half of the industry, outperforming 72.58% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ZJYL is in line with the industry average of 8.84%.
The 3 year average ROIC (9.49%) for ZJYL is well above the current ROIC(3.84%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.69% | ||
| ROE | 6.42% | ||
| ROIC | 3.84% |
ROA(3y)9.9%
ROA(5y)10.46%
ROE(3y)14.18%
ROE(5y)16.34%
ROIC(3y)9.49%
ROIC(5y)11.9%
1.3 Margins
With an excellent Profit Margin value of 7.85%, ZJYL belongs to the best of the industry, outperforming 80.11% of the companies in the same industry.
ZJYL's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 8.57%, ZJYL is doing good in the industry, outperforming 77.42% of the companies in the same industry.
In the last couple of years the Operating Margin of ZJYL has declined.
With a Gross Margin value of 35.79%, ZJYL is not doing good in the industry: 71.51% of the companies in the same industry are doing better.
ZJYL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.57% | ||
| PM (TTM) | 7.85% | ||
| GM | 35.79% |
OM growth 3Y6.9%
OM growth 5Y-6.46%
PM growth 3Y7.26%
PM growth 5Y-2.67%
GM growth 3Y9.69%
GM growth 5Y1.86%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZJYL is creating some value.
Compared to 1 year ago, ZJYL has more shares outstanding
Compared to 5 years ago, ZJYL has less shares outstanding
Compared to 1 year ago, ZJYL has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.81 indicates that ZJYL is not a great score, but indicates only limited risk for bankruptcy at the moment.
ZJYL has a better Altman-Z score (2.81) than 70.43% of its industry peers.
ZJYL has a Debt/Equity ratio of 0.56. This is a neutral value indicating ZJYL is somewhat dependend on debt financing.
ZJYL has a Debt to Equity ratio of 0.56. This is in the lower half of the industry: ZJYL underperforms 60.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.81 |
ROIC/WACC0.58
WACC6.63%
2.3 Liquidity
ZJYL has a Current Ratio of 2.11. This indicates that ZJYL is financially healthy and has no problem in meeting its short term obligations.
ZJYL has a Current ratio (2.11) which is comparable to the rest of the industry.
A Quick Ratio of 1.90 indicates that ZJYL should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.90, ZJYL is in line with its industry, outperforming 51.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.11 | ||
| Quick Ratio | 1.9 |
3. Growth
3.1 Past
ZJYL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.04%.
Measured over the past 5 years, ZJYL shows a small growth in Earnings Per Share. The EPS has been growing by 3.28% on average per year.
ZJYL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.42%.
Measured over the past years, ZJYL shows a small growth in Revenue. The Revenue has been growing by 2.90% on average per year.
EPS 1Y (TTM)-39.04%
EPS 3Y5.52%
EPS 5Y3.28%
EPS Q2Q%-105.22%
Revenue 1Y (TTM)13.42%
Revenue growth 3Y4.22%
Revenue growth 5Y2.9%
Sales Q2Q%-6.4%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ZJYL is valuated rather expensively with a Price/Earnings ratio of 21.58.
Based on the Price/Earnings ratio, ZJYL is valued cheaper than 80.65% of the companies in the same industry.
ZJYL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.58 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -7.71 |
4.3 Compensation for Growth
The decent profitability rating of ZJYL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)6.58
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ZJYL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
0.2158
-0.01 (-3.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.14%
Inst Owner Change-66.97%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap33.78M
Revenue(TTM)22.83M
Net Income(TTM)1.79M
AnalystsN/A
Price TargetN/A
Short Float %0.58%
Short Ratio0.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.58 | ||
| Fwd PE | N/A | ||
| P/S | 1.48 | ||
| P/FCF | N/A | ||
| P/OCF | 25.89 | ||
| P/B | 1.21 | ||
| P/tB | 1.26 | ||
| EV/EBITDA | -7.71 |
EPS(TTM)0.01
EY4.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.01
OCFY3.86%
SpS0.15
BVpS0.18
TBVpS0.17
PEG (NY)N/A
PEG (5Y)6.58
Graham Number0.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.69% | ||
| ROE | 6.42% | ||
| ROCE | 7.04% | ||
| ROIC | 3.84% | ||
| ROICexc | 13.32% | ||
| ROICexgc | 14.59% | ||
| OM | 8.57% | ||
| PM (TTM) | 7.85% | ||
| GM | 35.79% | ||
| FCFM | N/A |
ROA(3y)9.9%
ROA(5y)10.46%
ROE(3y)14.18%
ROE(5y)16.34%
ROIC(3y)9.49%
ROIC(5y)11.9%
ROICexc(3y)22.47%
ROICexc(5y)22.7%
ROICexgc(3y)23.46%
ROICexgc(5y)23.49%
ROCE(3y)12.88%
ROCE(5y)15.84%
ROICexgc growth 3Y-2.39%
ROICexgc growth 5Y-7.19%
ROICexc growth 3Y-4.58%
ROICexc growth 5Y-8.54%
OM growth 3Y6.9%
OM growth 5Y-6.46%
PM growth 3Y7.26%
PM growth 5Y-2.67%
GM growth 3Y9.69%
GM growth 5Y1.86%
F-Score4
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.13 | ||
| Cap/Depr | 847.75% | ||
| Cap/Sales | 9.25% | ||
| Interest Coverage | 5.51 | ||
| Cash Conversion | 59.19% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.11 | ||
| Quick Ratio | 1.9 | ||
| Altman-Z | 2.81 |
F-Score4
WACC6.63%
ROIC/WACC0.58
Cap/Depr(3y)178.09%
Cap/Depr(5y)117.95%
Cap/Sales(3y)1.86%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.04%
EPS 3Y5.52%
EPS 5Y3.28%
EPS Q2Q%-105.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.42%
Revenue growth 3Y4.22%
Revenue growth 5Y2.9%
Sales Q2Q%-6.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.9%
EBIT growth 3Y11.4%
EBIT growth 5Y-3.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.18%
OCF growth 3YN/A
OCF growth 5YN/A
JIN MEDICAL INTERNATIONAL LT / ZJYL FAQ
Can you provide the ChartMill fundamental rating for JIN MEDICAL INTERNATIONAL LT?
ChartMill assigns a fundamental rating of 4 / 10 to ZJYL.
Can you provide the valuation status for JIN MEDICAL INTERNATIONAL LT?
ChartMill assigns a valuation rating of 2 / 10 to JIN MEDICAL INTERNATIONAL LT (ZJYL). This can be considered as Overvalued.
What is the profitability of ZJYL stock?
JIN MEDICAL INTERNATIONAL LT (ZJYL) has a profitability rating of 6 / 10.
What are the PE and PB ratios of JIN MEDICAL INTERNATIONAL LT (ZJYL) stock?
The Price/Earnings (PE) ratio for JIN MEDICAL INTERNATIONAL LT (ZJYL) is 21.58 and the Price/Book (PB) ratio is 1.21.